Neurocrine Biosciences Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NBIX | A | Neurocrine Biosciences, Inc. | -2.24 | |
SPRB | F | Spruce Biosciences, Inc. | 3.37 |
Related Industries: Biotechnology
Related Stock Lists:
Alcohol
Biopharmaceutical
Cardiovascular Disease
Clinical Development
Congenital Adrenal Hyperplasia
Diabetes
Disorders
Dyskinesia
Endocrine Disorders
Endometriosis
Epilepsy
Essential Tremor
Ethers
Fibroids
Gnrh Antagonists
Hormones
Hyperplasia
Insomnia
Medicine
Movement Disorders
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | C | PowerShares Dynamic Biotech & Genome | 5.53 | |
IBRN | C | iShares Neuroscience and Healthcare ETF | 5.08 | |
MNTL | F | Tema Neuroscience and Mental Health ETF | 4.27 | |
FBT | D | First Trust Amex Biotech Index Fund | 3.49 | |
JSMD | C | Janus Small/Mid Cap Growth Alpha ETF | 3.27 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Alcohol
Biopharmaceutical
Cardiovascular Disease
Clinical Development
Congenital Adrenal Hyperplasia
Diabetes
Disorders
Dyskinesia
Endocrine Disorders
Endometriosis
Epilepsy
Essential Tremor
Ethers
Fibroids
Gnrh Antagonists
Hormones
Hyperplasia
Insomnia
Medicine
Movement Disorders
- Neurocrine Biosciences
Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles